Methylation of Estrogen Receptor DNA in Breast Cancer
Author Information
Author(s): R. Piva, A.P. Rimondi, S. Hanau, I. Maestri, A. Alvisi, V.L. Kumar, L. del Senno
Primary Institution: Istituto di Chimica Biologica e Centro di Studi Biochimici delle Patologie del Genoma Umano, Universitad di Ferrara, Italy
Hypothesis
DNA methylation could be involved in the control of estrogen receptor gene expression in breast cancer.
Conclusion
Abnormal methylation patterns of the estrogen receptor gene are common in breast carcinomas and differ from those in normal breast tissue.
Supporting Evidence
- 30% of breast tumors showed hypomethylation of certain DNA regions.
- ER + carcinomas had lower methylation in the 5' region compared to ER - carcinomas.
- Breast cancer cell lines exhibited different methylation patterns compared to primary tumors.
Takeaway
This study found that the way DNA is marked in breast cancer cells is different from normal cells, which might affect how the cancer grows.
Methodology
The study analyzed DNA methylation in breast cancer tissues and cell lines using restriction enzymes and immunocytochemical assays.
Limitations
The study does not address the potential influence of the menstrual cycle on methylation patterns.
Participant Demographics
Patients aged 40 to 80 years, with 4 premenopausal and 16 post-menopausal women.
Want to read the original?
Access the complete publication on the publisher's website